Crista Galli Ventures

Crista Galli Ventures backs founders building the century of biology, partnering with visionary founders at the nexus of bio, tech, and medicine. The firm invests in three key verticals: TechBio (computational biology and programmable biology), DeepTech Healthcare (AI-enabled clinical tools, medical devices, and data-driven diagnostics), and Digital Health (reimagined care delivery and patient-centered technology). Their thesis centers on the belief that biology is becoming programmable through the convergence of computational tools, synthetic biology, and molecular insight, enabling personalized medicine. They focus on salutogenesis rather than pathogenesis—maintaining health rather than waiting for disease to unfold. The firm looks for scientific differentiation, exceptional founders with rare combinations of domain expertise and execution ability, meaningful patient impact addressing significant unmet medical needs, and deep understanding of how technology integrates into clinical workflows. As an evergreen fund backed by the family office IPQ Capital, Crista Galli operates with patient capital, thinking in decades rather than quarters.